Palma, Jose-Alberto http://orcid.org/0000-0002-1345-6774
Vernetti, Patricio Millar
Perez, Miguel A.
Krismer, Florian
Seppi, Klaus
Fanciulli, Alessandra
Singer, Wolfgang
Low, Phillip
Biaggioni, Italo
Norcliffe-Kaufmann, Lucy
Pellecchia, Maria Teresa
Martí, Maria José
Kim, Han-Joon
Merello, Marcelo
Stankovic, Iva
Poewe, Werner
Betensky, Rebecca
Wenning, Gregor
Kaufmann, Horacio
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (U54NS065736, R01NS107596)
Multiple System Atrophy Coalition
Article History
Received: 18 December 2020
Accepted: 27 January 2021
First Online: 7 February 2021
Compliance with ethical standards
:
: Dr. Palma: salary from Novartis Gene Therapies. Research funding from the NIH, Michael J. Fox Foundation, MSA Coalition, Familial Dysautonomia Foundation, FDA, and Biogen; advisory board member for Lundbeck, Biogen, PTC Therapeutics, Astellas, and Dr. Reddy’s Laboratories; managing editor of <i>Clinical Autonomic Research</i>; principal investigator in MSA studies funded by Biohaven Pharmaceuticals, Theravance Biopharma, and Biogen. Dr. Millar: research funding from the Familial Dysautonomia Foundation and Theravance Biopharma. Mr. Perez: research funding from the Familial Dysautonomia Foundation. Dr. Krismer: funding support from MSA Coalition, non-financial support from International Parkinson’s Disease and Movement Disorders Society, non-financial support from Austrian Parkinson’s Disease Society. Dr. Fanciulli: royalties from Springer Nature Publishing Group, Thieme Verlag and IOS Press, speaker fees and honoraria from the Austrian Parkinson Society, International Parkinson Disease and Movement Disorders Society, French Cardiology Society, Theravance Biopharma and research Grants from the Stichting Parkinson Fond, the Österreichischer Austausch Dienst and the MSA Coalition. Dr. Norcliffe-Kaufmann: research funding from the NIH, Michael J. Fox Foundation, MSA Coalition, Familial Dysautonomia Foundation, FDA; advisory fees from Theravance Biopharma, and PTC Therapeutics. Dr. Kim: research finding from Seoul National University Hospital and C-TRI. Dr. Merello: Editor-in-Chief of <i>Movement Disorders Clinical Practice</i>. Dr. Stankovic: speaker honoraria from International Parkinson Disease and Movement Disorders Society. Dr. Kaufmann: research funding from the NIH, Michael J. Fox Foundation, MSA Coalition, Familial Dysautonomia Foundation, FDA, and Biogen; is an advisory Board Member for Lundbeck, Biogen, Biohaven, Theravance, PTC Therapeutics, ONO and Lilly; is Editor-in-Chief of <i>Clinical Autonomic Research</i>.
Free to read: This content has been made available to all.